Table 7

Mean (SD) of LANCP volume (mm3) in SLE subgroups

Demographic and clinical variablesSubgroupLANCP mean
(SD)
P value
SexFemale (n=57)453 (217)0.6325
Male (n=9)489 (136
RaceWhite (n=43)459 (223)0.3823
Black (n=19)483 (180)
Other (n=4)324 (107)
Age at baseline<45 (n=22)396 (129)0.0115
45–59 (n=38)459 (144)
60+ (n=6)676 (512)
History of smokingEver (n=20)413 (147)0.2482
Never (n=46)478 (228)
History of lupus anticoagulantYes (n=23)504 (291)0.1880
No (n=43)433 (143)
History of anticardiolipinYes (n=46)450 (236)0.6527
No (n=20)476 (122)
Current cholesterol 200+Yes (n=12)465 (218)0.6042
No (n=53)430 (168)
Current BMI<25(n=25)430 (284)0.3007
25–30 (n=21)434 (118)
>30 (n=20)518 (158)
Current anti-dsDNAYes (n=13)517 (375)0.2558
No (n=53)443 (143)
Current low complementYes (n=16)469 (354)0.8116
No (n=50)454 (137)
Current hydroxychloroquine useYes (n=56)466 (215)0.4677
No (n=10)414 (158)
Current prednisone use<10 mg/day (n=62)436 (143)0.0004
≥10 mg/day (n=4)800 (591)
Current SLEDAI≤3 (n=48)445 (135)0.4198
>3 (n=18)492 (335)
Hypertension or antihypertensive useYes (n=46)482 (236)0.1629
No (n=20)404 (107)
  • BMI, body mass index; LANCP, low-attenuation non-calcified plaque; SLE, systemic lupus erythematosus.